Skip to main content
. 2017 Dec 14;25(3):320–328. doi: 10.1177/1933719117746764

Figure 4.

Figure 4.

Expression of heart- and neural crest derivatives-expressed protein 2 (HAND2) is reduced in human endometrial biopsies exposed to mifepristone. Upper: Immunohistochemical analysis of HAND2 in human endometrium before (panel A) and after administration of 50 mg of oral mifepristone every other day for 12 weeks of the menstrual cycle (panel B). Representative images are shown. Lower: HSCOREs of HAND2-positive cells in the endometrium revealed a significant reduction in HAND2 expression in mifepristone-exposed biopsies when compared to unexposed controls (N = 6). B indicates baseline (0 wks) and after 12 weeks (12 wks) indicates end of treatment, and they show a significant decrease (P < .02).